Ruane Cunniff

Ruane Cunniff

Last Update: 05-16-2016

Number of Stocks: 133
Number of New Stocks: 11

Total Value: $12,872 Mil
Q/Q Turnover: 3%

Countries: USA SGP
Details: Top Buys | Top Sales | Top Holdings  Embed:

Ruane Cunniff' s Profile & Performance

Profile

This is the firm founded by William Ruane, who died in Oct. 2005. We continue to track its stock picks. The current investment committee is directed by Richard T. Cunniff. William Ruane is a Graham-and-Doddsville superinvestor recognized by Warren Buffett. William Ruane was founder and Chairman of Sequoia Fund, Inc. (SEQUX). Since inception in 1970 through September 30, 2007, the Fund has returned 15.57% average annually. During the same period the S&P 500 returned an average 11.86% annually. He is a student of Benjamin Graham, and attended his class at the same time as Warren Buffett.

Web Page:http://www.sequoiafund.com/

Investing Philosophy

Ruane Cunniff are value investors focused on the intrinsic value of business. They are long-term investors, and will buy a stock and hold it for a long time, even if sometimes the stocks seem to be overvalued. They look at common stocks as units of ownership in a business, and purchase them when the price appears low in relation to the value of the total enterprise. The Firm shuns technical stock market studies, and looks at the balance sheet, earnings history, and prospects of each investment when determining its value.

Total Holding History

Performance of Sequoia Fund

YearReturn (%)S&P500 (%)Excess Gain (%)
20147.5513.69-6.1
201334.5832.392.2
201215.6816-0.3
3-Year Cumulative67.4 (18.7%/year)74.6 (20.4%/year)-7.2 (-1.7%/year)
201113.192.1111.1
201019.515.064.4
5-Year Cumulative126.5 (17.8%/year)105.1 (15.5%/year)21.4 (2.3%/year)
200915.3826.46-11.1
2008-27.03-3710.0
20078.45.492.9
20068.3415.79-7.4
20057.784.912.9
10-Year Cumulative141.4 (9.2%/year)109.4 (7.7%/year)32 (1.5%/year)
20044.6610.88-6.2
200317.1228.68-11.6
2002-2.64-22.119.5
200110.52-11.8922.4
200020.06-9.129.2
15-Year Cumulative282.2 (9.4%/year)86.4 (4.2%/year)195.8 (5.2%/year)
1999-16.5421.04-37.6
199835.2528.586.7
199743.233.369.8
199621.7422.96-1.2
199541.3837.583.8
20-Year Cumulative963.3 (12.5%/year)554.6 (9.8%/year)408.7 (2.7%/year)
19943.341.322.0
199310.7810.080.7
19929.367.621.7
19914030.479.5
1990-3.8-3.1-0.7
25-Year Cumulative1692.9 (12.2%/year)893.3 (9.6%/year)799.6 (2.6%/year)
198927.9131.69-3.8
198811.0516.61-5.6
19877.45.12.3
198613.3818.6-5.2
198527.9531.6-3.6
30-Year Cumulative3867.9 (13.1%/year)2402.2 (11.3%/year)1465.7 (1.8%/year)
198418.56.112.4
198327.3122.44.9
198231.1221.49.7
198121.49-526.5
198012.6632.3-19.6
35-Year Cumulative10642.9 (14.3%/year)4858.2 (11.8%/year)5784.7 (2.5%/year)

Top Ranked Articles

Ruane Cunniff Sells Shares of Goldman Sachs, IBM Top trades during the 4th quarter
Ruane, Cunniff & Goldfarb Inc. was founded by William Ruane, who died in October 2005. GuruFocus continues to track the firm's stock picks. During the fourth quarter, the firm sold many stocks including the following. Read more...
Ruane Cunniff Boosts Time Warner During 4th Quarter Investor's top buys includes Valeant Pharmaceuticals
Ruane Cunniff (Trades, Portfolio) is a value investor focused on the intrinsic value of business. It is a long-term investor and will buy a stock and hold it for a long time, even if sometimes the stocks seem to be overvalued. Its largest buys during the fourth quarter were: Read more...
Bob Goldfarb Steps Down at Sequoia Fund Sequoia Fund is in a lot of trouble due to an oversized bet on Valeant, and its rating is under review by Morningstar
There are three gurus who are suffering tremendously through big concentrated bets on Valeant (NYSE:VRX) that backfired starting at the end of last year. Read more...
Sequoia CEO and Portfolio Manager Resigns Amid Valeant Losses Co-manager David Poppe will replace Goldfarb as Ruane Cunniff CEO
Saying it will take a more collaborative approach to portfolio management, Ruane Cuniff announced Wednesday the resignation of CEO and Co-Manager Bob Goldfarb, who led the fund to 14% annual returns and had a 45-year investing career before the losses from its outsized position troubled pharmaceutical company Valeant (NYSE:VRX). Read more...
Ackman Named to Valeant Board as Search for New CEO Begins Valeant has asked CFO Howard Schiller to resign
Valeant Pharmaceuticals (NYSE:VRX) announced today that it will replace CEO Michael Pearson and name major shareholder Bill Ackman (Trades, Portfolio) to the board of directors. Pearson will continue to serve as CEO until a successor is named, and Katharine Stevenson will resign from the board to make room for Ackman. Read more...
» More Ruane Cunniff Articles

Commentaries and Stories

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Ruane Cunniff Sells Shares of Goldman Sachs, IBM Top trades during the 4th quarter Ruane Cunniff - Ruane Cunniff Sells Shares Of Goldman Sachs, IBM
Ruane, Cunniff & Goldfarb Inc. was founded by William Ruane, who died in October 2005. GuruFocus continues to track the firm's stock picks. During the fourth quarter, the firm sold many stocks including the following. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Ruane Cunniff Boosts Time Warner During 4th Quarter Investor's top buys includes Valeant Pharmaceuticals Ruane Cunniff,Warren Buffett,Jeremy Grantham,Walla - Ruane Cunniff Boosts Time Warner During 4th Quarter
Ruane Cunniff (Trades, Portfolio) is a value investor focused on the intrinsic value of business. It is a long-term investor and will buy a stock and hold it for a long time, even if sometimes the stocks seem to be overvalued. Its largest buys during the fourth quarter were: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Bob Goldfarb Steps Down at Sequoia Fund Sequoia Fund is in a lot of trouble due to an oversized bet on Valeant, and its rating is under review by Morningstar Ruane Cunniff,Warren Buffett - Bob Goldfarb Steps Down At Sequoia Fund
There are three gurus who are suffering tremendously through big concentrated bets on Valeant (NYSE:VRX) that backfired starting at the end of last year. More...

LONG, FUND


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Sequoia CEO and Portfolio Manager Resigns Amid Valeant Losses Co-manager David Poppe will replace Goldfarb as Ruane Cunniff CEO Ruane Cunniff - Sequoia CEO And Portfolio Manager Resigns Amid Valeant Losses
Saying it will take a more collaborative approach to portfolio management, Ruane Cuniff announced Wednesday the resignation of CEO and Co-Manager Bob Goldfarb, who led the fund to 14% annual returns and had a 45-year investing career before the losses from its outsized position troubled pharmaceutical company Valeant (NYSE:VRX). More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Ackman Named to Valeant Board as Search for New CEO Begins Valeant has asked CFO Howard Schiller to resign Bill Ackman, Ruane Cunniff - Ackman Named To Valeant Board As Search For New CEO Begins
Valeant Pharmaceuticals (NYSE:VRX) announced today that it will replace CEO Michael Pearson and name major shareholder Bill Ackman (Trades, Portfolio) to the board of directors. Pearson will continue to serve as CEO until a successor is named, and Katharine Stevenson will resign from the board to make room for Ackman. More...

  • Currently 5.00/5

Rating: 5.0/5 (10 votes)

Morningstar Reviews Sequoia Fund Rating Due to Valeant Losses Analysts question fund's actions with Valeant; fund has won with outsized positions in the past Ruane Cunniff - Morningstar Reviews Sequoia Fund Rating Due To Valeant Losses
A fund that once boasted one of the best long-term track records and a friendly relationship with Warren Buffett (Trades, Portfolio) found itself maimed by a series of negative developments at its top holding, Valeant Pharmaceuticals (NYSE:VRX) in recent months. The stock’s months-long plunge and Sequoia’s large exposure prompted mutual funds rating company Morningstar to place its analyst rating under review Wednesday. It also caused Sequoia’s manager to say their “credibility as investors has been damaged by this saga,” but few saw the sinkhole coming. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Pershing Square Gains Board Seat on Valeant Bill Ackman says Valeant could sell off Bausch & Lomb segment to pay debt Bill Ackman,Ruane Cunniff,Jeff Ubben,John Paulson, - Pershing Square Gains Board Seat On Valeant
Activist investor Bill Ackman (Trades, Portfolio) of Pershing Square has landed a representative on the board of Valeant Pharmaceuticals (NYSE:VRX), the controversy-ridden company whose stock has tanked over the past year, possibly giving investors hope that Pershing can orchestrate a turnaround. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Chase Coleman Sells Autohome, IBM in 4th Quarter Most sales did not greatly impact portfolio Chase Coleman,Ruane Cunniff,Ken Fisher,Steven Cohe - Chase Coleman Sells Autohome, IBM In 4th Quarter
Chase Coleman (Trades, Portfolio) is the founder of Tiger Global Management. During the fourth quarter he sold many stocks. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Sequoia Fund Comments on Rolls-Royce Guru stock highlight
Our European holdings continued to turn in poor performance. Rolls-Royce (LSE:RR.) fired its CEO John Rishton and replaced him with a board member, Warren East, who had great success leading the semiconductor company ARM Holdings. Mr. East knows what he is doing but he’s got his work cut out for him as he tries to improve operating discipline at this inefficient manufacturer. Rolls and our UK holding IMI plc were the two worst-performing stocks in Sequoia, each declining about 35% in dollars. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Sequoia Fund Comments on Berkshire Hathaway Guru stock highlight
Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B), our second largest holding, declined by 12.5% during the year. Berkshire now trades at less than 12 times our estimate of 2016 earnings. We think Berkshire grew its earnings at a high-single digit rate in 2015 but many of its individual operating companies face challenges. Railroad volumes declined abruptly at year-end and the outlook for 2016 volume is poor. GEICO’s auto insurance profit was off and many of Berkshire’s other service and manufacturing businesses were soft. Berkshire committed over $40 billion to acquisitions in 2015, the bulk of it to buy Precision Castparts. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Sequoia Fund Comments on Valeant Pharmaceuticals Guru stock highlight
Sequoia turned in its second straight year of poor results in 2015.Teasing out the source of our underperformance doesn’t take much work. We began the year with a 20% weighting in Valeant Pharmaceuticals (NYSE:VRX). Valeant rose by more than 80% through the summer, driving very strong gains for the Fund. But the price collapsed in the fall amid revelations and allegations about the company’s business practices. Ultimately, Valeant declined 29% for the year and by more than 70% from its 52-week high to its low. We bought more shares in October, and we calculate that Valeant contributed -6.3% to Sequoia’s return of -7.3% for the year. More...

  • Currently 3.00/5

Rating: 3.0/5 (2 votes)

Sequoia Fund Releases 4th Quarter Shareholder Letter Managers address Valeant stake, second consecutive losing year, 'bear market for stocks' Ruane Cunniff - Sequoia Fund Releases 4th Quarter Shareholder Letter
Dear Shareholder: More...

  • Currently 3.00/5

Rating: 3.0/5 (2 votes)

Ruane Cunniff Adds to Valeant Stake, Buys 3 New Stocks The Sequoia Fund distributor bought more shares as it defended the controversial Valeant Pharmaceuticals in Q4 Ruane Cunniff - Ruane Cunniff Adds To Valeant Stake, Buys 3 New Stocks
When controversy erupted over Valeant Pharmaceuticals’ accounting practices last quarter, advisers and investors parted ways over the stock. The Sequoia Fund in particular both suffered large losses due to its outsized position in the company and defended its questioned relationship with a pharmacy, Philidor, and astronomical drug price increases. Last week, Ruane Cunniff, the distributor of the Sequoia Fund, reported that it added more share of Valeant and bought three new stocks during the fourth quarter. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

O'Reilly and ConAgra Foods Are Outperforming the Market Guru stocks that have beaten the S&P 500 index Ruane Cunniff, Chuck Akre, Mario Gabelli - O'Reilly And ConAgra Foods Are Outperforming The Market
The following are some of the stocks that outperformed the S&P 500 Index over the last 12 months and have been bought by gurus during the last quarter. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

5 Stocks Reach 5-Year Lows Prices for Iron Mountain, FMC, Liberty Property Trust, Range Resources, BOK Financial tumble Wallace Weitz,Ruane Cunniff, - 5 Stocks Reach 5-Year Lows
According to GuruFocus list of five-year lows, these guru stocks have reached their five-year lows: Iron Mountain Inc. (NYSE:IRM), FMC Corp. (NYSE:FMC), Liberty Property Trust (NYSE:LPT), Range Resources Corp. (NYSE:RRC), BOK Financial Corp. (NASDAQ:BOKF). More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Ruane Cunniff's Top New Buys of 3rd Quarter Allergan, Time Warner Cable and Vipshop Holdings have new positions in the portfolio Ruane Cunniff,Paul Singer,Wallace Weitz,Jim Simons - Ruane Cunniff's Top New Buys Of 3rd Quarter
Ruane Cunniff was founded by William Ruane. The Fund’s investment objective is long-term growth of capital. In pursuing this objective the Fund focuses on investing in equity securities that it believes are undervalued at the time of purchase and have the potential for growth. More...

  • Currently 4.00/5

Rating: 4.0/5 (1 vote)

Ruane Cunniff's Best Value Holdings Construction firm Jacobs Engineering among the attractive stocks in portfolio Ruane Cunniff - Ruane Cunniff's Best Value Holdings
Ruane Cunniff (Trades, Portfolio) is a value investment fund focused on the intrinsic value of businesses. The company was founded by William Ruane, who died in 2005, and was recognized by Warren Buffett (Trades, Portfolio) as a “superinvestor.” The firm continues his legacy by finding businesses that meet their stringent qualities of high-quality, which should allow investor capital to compound over the long-term. The company has extremely low turnover and will own businesses for a very long period of time, even if the stock appears to be overvalued. The fund has come under flack of late because of its massive position in Valeant (VRX). More...

LONG, JEC, IBM, OMC


  • Currently 3.33/5

Rating: 3.3/5 (3 votes)

Hillary and Citron Research Do Not Scare Goldfarb and Poppe Sequoia Fund recently increased its stake in Valeant and bought into Allergan which is surprising given the controversial nature of these positions Warren Buffett,Ruane Cunniff,Bill Ackman - Hillary And Citron Research Do Not Scare Goldfarb And Poppe
Ruane Cunniff & Goldfarb was founded by William Ruane (1925- 2005). Warren Buffett (Trades, Portfolio) always spoke highly of Ruane, both attended the same class by Graham, but the firm is also considered of guru level because of its long-term track record and strong value investing fundamental approach. The firm is best known for its Sequoia Fund Inc., which has trounced the Standard & Poor's 500 since inception in 1970. One thing to keep in mind is that Ruane Cunniff (Trades, Portfolio) focused on the intrinsic value of business, but they are committed to the long term and will buy a stock and hold it even through periods of modest overvaluation. The fund is managed by Robert Goldfarb, 67, and David Poppe, 47. More...

HEALTHCARE, LONG


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Four Solid Dividend Payers With Yields Near the Historical High New filters in the All-In-One Screener offer enhanced dividend searches Ruane Cunniff,Ron Baron,Warren Buffett,Jeremy Gran - Four Solid Dividend Payers With Yields Near The Historical High
Recently, GuruFocus introduced new filters to the Dividend tab in the All-In-One Screener that will better help income investors narrow their stock choices. More...

DIVIDEND, IBM, WALMART, FASTENAL


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Ruane Cunniff Adds to Stake in Monsanto California's EPA concludes ingredient in weed killer is hazardous to humans Ruane Cunniff - Ruane Cunniff Adds To Stake In Monsanto
The intrinsic value of business is Ruane Cunniff (Trades, Portfolio)’s focus when making investment decisions, and its success is clear. Its Sequoia Fund outperformed the S&P 500 from the time the Fund began in 1970 until September 2007, and its record in recent years hasn’t been bad, either. Last year, the Fund returned 7.55%, but that is a drop in the bucket compared to its returns in 2013 (34.58%). More...

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK